Adhesion Failure during die-cutting: process parameter review and validation impact


Published on 30/12/2025

Understanding Adhesion Failure during Die-Cutting: A Comprehensive Investigation

Adhesion failure during die-cutting in pharmaceutical manufacturing can lead to significant product quality issues, especially in transdermal drug delivery systems. Such failures can result in nonconforming products, complaints, and regulatory scrutiny. This article provides a structured approach to investigate adhesion failure incidents, encompassing signal identification, root cause analysis, and corrective and preventive actions (CAPA).

By the end of this guide, readers will understand how to systematically approach adhesion failures during die-cutting, assess the probable causes, contain the issue promptly, and develop robust control strategies that ensure compliance with GMP regulations and readiness for FDA, EMA, or MHRA inspections.

Symptoms/Signals on the Floor or in the Lab

Identifying the symptoms or signals of adhesion failure is crucial for prompt intervention. Typical signs may include:

  • Products exhibiting incomplete adhesion to release liners or substrates.
  • Inconsistent or poor bonding during manufacturing tests.
  • Customer complaints regarding product performance or efficacy.
  • Unexpected observations during stability studies showing reduced adhesive qualities over time.
  • Deviations recorded during in-process quality checks that fall outside acceptance criteria.

Regular training

of personnel to recognize these symptoms is vital for timely communication and action.

Likely Causes

Understanding the likely causes of adhesion failure during die-cutting involves considering various categories: Materials, Method, Machine, Man, Measurement, and Environment. Below is an outline of potential causes under each category:

Category Likely Causes
Materials Incompatibility of adhesive formulation or release liner composition.
Method Poorly defined die-cutting parameters such as pressure, speed, or dwell time.
Machine Equipment malfunction or misalignment affecting die performance.
Man Operator errors in following the standard operating procedures (SOPs).
Measurement Inaccurate or inadequate testing methods for adhesive strength.
Environment Temperature and humidity fluctuations affecting adhesion properties.

Immediate Containment Actions (first 60 minutes)

During the first hour of identifying adhesion failure, immediate containment actions should be prioritized to minimize potential impact:

  1. Stop the production line and isolate affected batches.
  2. Document the time, date, and personnel involved in the incident.
  3. Notify quality assurance (QA) and management teams.
  4. Conduct a quick assessment of ongoing operations to determine if other batches may be impacted.
  5. Implement a temporary hold on all related products pending further investigation.
  6. Begin collecting physical samples from affected batches for testing.
Pharma Tip:  Residual Solvent Oos in transdermal patch manufacturing: process parameter review and validation impact

Timely containment is essential to prevent further nonconformances and safeguard product quality.

Investigation Workflow

The investigation workflow for an adhesion failure involves a systematic collection and analysis of data. Follow these steps:

  1. Collect batch records, production logs, and deviation reports related to the impacted lots.
  2. Review the raw material and adhesive specifications, including supplier certificates of analysis (CoA).
  3. Evaluate environmental control records and equipment maintenance logs from the operational period.
  4. Conduct interviews with operators and quality control staff for insight into any procedural deviations or anomalies noted during the die-cutting process.
  5. Perform a trend analysis on adhesion test results of historical batches compared to affected lots.

Interpreting this data will help to identify patterns and assist in narrowing down the root causes of the failure.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Several root cause analysis tools can be employed to systematically determine the cause of adhesion failures:

  • 5-Why Analysis: Effective for straightforward issues where the root cause can be traced through several levels of inquiry. Start with the problem and ask ‘why?’ repetitively, typically five times, to delve into deeper causes.
  • Fishbone Diagram (Ishikawa): Beneficial for categorizing multiple potential causes, as it visually breaks down major categories (e.g., Materials, Method) into sub-factors. This is particularly useful for complex issues with varied inputs.
  • Fault Tree Analysis: Best suited for sophisticated or safety-critical processes, where you can analyze and visualize the paths leading to a failure. It provides a comprehensive view of how different failure modes can connect.

Selecting the appropriate tool based on complexity and nature of the issue is crucial for effective root cause identification.

CAPA Strategy (Correction, Corrective Action, Preventive Action)

Once the root cause is identified, it is essential to implement a robust CAPA strategy:

  1. Correction: Address the immediate failure by fixing the affected batches (if possible) and determining the right operational parameters for rescinded lots.
  2. Corrective Action: Establish actions to eliminate the root cause identified, such as retraining operators on SOPs for die-cutting or recalibrating equipment.
  3. Preventive Action: Develop preventive measures such as enhanced QC during the material intake process, implementation of real-time monitoring systems, and regular equipment maintenance checks to prevent degradation of adhesive performance.
Pharma Tip:  Ivpt Failure during EU/UK market supply: GMP investigation plan and CAPA

Documenting the CAPA strategy in detail is essential for regulatory compliance and future audits.

Control Strategy & Monitoring

A comprehensive control strategy plays a crucial role in sustaining quality throughout the die-cutting process:

  • Integrate Statistical Process Control (SPC) to monitor critical parameters affecting adhesion (e.g., humidity, temperature, and die-cutting speed).
  • Establish sampling plans to regularly assess adhesive performance throughout the production run.
  • Develop alarm systems for out-of-bounds alerts that indicate deviations from established parameters.
  • Utilize verification techniques post-production to establish whether corrective actions effectively mitigate adhesion issues.

Monitoring these controls will ensure sustained adherence to quality standards and readiness for inspections.

Validation / Re-qualification / Change Control Impact

Any changes in materials, processes, or equipment as a result of the investigation will necessitate reevaluation through validation, re-qualification, or change control processes:

Related Reads

  • Validation should be conducted if any alterations to adhesive formulations, die-cutting parameters, or equipment setups occur.
  • Re-qualification may be required for all related equipment to ensure consistent performance within specified limits post-adjustment.
  • Change control procedures must be updated to include any modifications made during the investigation, with proper documentation to justify changes under ICH guidelines.

Aligning these practices with regulatory expectations will support uninterrupted compliance and product quality integrity.

Inspection Readiness: What Evidence to Show

In preparation for regulatory inspections, documentation is crucial. Ensure the following records are readily accessible:

  • Batch manufacturing and control records detailing the production of affected lots.
  • Complete deviation reports and investigative documentation with findings and analysis.
  • CAPA records that detail corrective actions taken and preventive measures implemented.
  • Environmental monitoring logs that reflect conditions during the die-cutting process.
  • Validation and change control documentation outlining any procedural or material changes.
Pharma Tip:  Curling After Packaging during EU/UK market supply: root cause mapping across materials and process

Compiling thorough evidence demonstrates a proactive approach to quality assurance and can significantly influence inspection outcomes.

FAQs

What is adhesion failure in pharmaceutical manufacturing?

Adhesion failure refers to a loss of bond strength between adhesive components and substrates, leading to product performance issues.

How can adhesion issues affect product quality?

Adhesion failures can compromise drug delivery, efficacy, and patient safety, further leading to noncompliance with regulatory standards.

What should be included in a deviation report?

A deviation report should include the issue description, deviation details, investigation outcomes, root cause, and actions taken.

Are there specific regulatory guidelines for CAPA in pharmaceuticals?

Yes, regulatory bodies like the FDA, EMA, and MHRA provide guidelines that outline expectations for CAPA implementation.

What role does training play in preventing adhesion failure?

Training ensures operators are aware of SOPs and best practices, reducing the likelihood of human errors leading to adhesion issues.

How often should adhesive performance be tested?

Adhesive performance testing should be part of regular quality control procedures, tailored to meet specific manufacturing needs.

What is the importance of trend analysis in quality control?

Trend analysis allows for the identification of potential problems before they escalate, thus enabling preemptive actions to be taken.

Why is cross-functional collaboration important in investigations?

Cross-functional collaboration enhances perspective, ensuring all possible causes are explored and that comprehensive solutions are developed.

How can environmental factors affect adhesion?

Temperature, humidity, and other environmental conditions can alter adhesive properties, influencing performance and effectiveness.

What documentation supports effective change control?

Documentation should include change analysis, rationale, impact assessments, and demonstration of adherence to validation principles where applicable.

What steps should be taken following an inspection finding?

Following an inspection finding, immediate action should be taken to address the issues documented, establishing a plan for correction and prevention.

How can manufacturers ensure consistency in adhesive quality?

Manufacturers can ensure consistency through stringent supplier evaluations, regular testing of incoming materials, and stringent adherence to SOPs and quality controls.